Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype

Obesity is a complex multifactorial disease involving genetic and environmental factors and influencing several different metabolic pathways. In this regard, metabonomics, that is the study of complex metabolite profiles in biological samples, may provide a systems approach to understand the global metabolic regulation of the organism in relation to this peculiar pathology. In this pilot study, we have applied a nuclear magnetic resonance (NMR)-based metabolomic approach on urinary samples of morbidly obese subjects. Urine samples of 15 morbidly obese insulin-resistant (body mass index>40; homeostasis assessment model of insulin resistance>3) male patients and 10 age-matched controls were collected, frozen and analyzed by high-resolution 1H-NMR spectroscopy combined with partial least squares-discriminant analysis. Furthermore, two obese patients who underwent bariatric surgery (biliopancreatic diversion and gastric bypass, respectively) were monitored during the first 3 months after surgery and their urinary metabolic profiles were characterized. NMR-based metabolomic analysis allowed us to identify an obesity-associated metabolic phenotype (metabotype) that differs from that of lean controls. Gut flora-derived metabolites such as hippuric acid, trigonelline, 2-hydroxyisobutyrate and xanthine contributed most to the classification model and were responsible for the discrimination. These preliminary results confirmed that in humans the gut microflora metabolism is strongly linked to the obesity phenotype. Moreover, the typical obese metabotype is lost after weight loss induced by bariatric surgery.

[1]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[2]  C. Sjöström.  Bariatric Surgery: A Systematic Review and , 2008 .

[3]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[4]  J. Kral,et al.  Surgical treatment of obesity , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[5]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[6]  Z. Ramadan,et al.  Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. , 2007, Journal of proteome research.

[7]  I. Wilson,et al.  Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism , 2003, Nature Reviews Drug Discovery.

[8]  P. Turnbaugh,et al.  The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.

[9]  I. Wilson,et al.  A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.

[10]  Richard D Beger,et al.  Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K McPherson,et al.  FORESIGHT TACKLING OBESITIES: FUTURE CHOICES , 2011 .

[13]  Alfred Ross,et al.  Chapter 3 – NMR Spectroscopy Techniques for Application to Metabonomics , 2007 .

[14]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[15]  Federico Marini,et al.  The Influence of a Sports Drink on the Postexercise Metabolism of Elite Athletes as Investigated by NMR-Based Metabolomics , 2009, Journal of the American College of Nutrition.

[16]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[17]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[18]  R. Goodacre.  Metabolomics of a superorganism. , 2007, The Journal of nutrition.

[19]  M. Rantalainen,et al.  Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. , 2009, Journal of proteome research.

[20]  E. Mun,et al.  Surgical management of morbid obesity. , 2005, Diabetes care.

[21]  John C. Lindon,et al.  The handbook of metabonomics and metabolomics , 2007 .

[22]  S. Yamashita,et al.  Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. , 1998, Metabolism: clinical and experimental.

[23]  L. Eriksson.  Multi- and megavariate data analysis , 2006 .

[24]  J. Nicholson.  Global systems biology, personalized medicine and molecular epidemiology , 2006, Molecular systems biology.

[25]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[26]  H. Vogel,et al.  Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse , 2008, Diabetes, obesity & metabolism.

[27]  D. Bessesen.  Meta-analysis: Surgical Treatment of Obesity , 2006 .

[28]  Patrice D Cani,et al.  The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.